- Home
- CLPT vs CDXS Comparison
CLPT vs CDXS Comparison
Compare CLPT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- CDXS
- Stock Information
- Founded
- CLPT 1998
- CDXS 2002
- Country
- CLPT United States
- CDXS United States
- Employees
- CLPT N/A
- CDXS N/A
- Industry
- CLPT Medical/Dental Instruments
- CDXS Major Chemicals
- Sector
- CLPT Health Care
- CDXS Industrials
- Exchange
- CLPT Nasdaq
- CDXS Nasdaq
- Market Cap
- CLPT 317.4M
- CDXS 254.3M
- IPO Year
- CLPT N/A
- CDXS 2010
- Fundamental
- Price
- CLPT $10.49
- CDXS $2.43
- Analyst Decision
- CLPT Strong Buy
- CDXS Buy
- Analyst Count
- CLPT 3
- CDXS 2
- Target Price
- CLPT $27.67
- CDXS $11.00
- AVG Volume (30 Days)
- CLPT 281.4K
- CDXS 1.3M
- Earning Date
- CLPT 11-06-2025
- CDXS 10-30-2025
- Dividend Yield
- CLPT N/A
- CDXS N/A
- EPS Growth
- CLPT N/A
- CDXS N/A
- EPS
- CLPT N/A
- CDXS N/A
- Revenue
- CLPT $33,593,000.00
- CDXS $57,164,000.00
- Revenue This Year
- CLPT $22.34
- CDXS $12.88
- Revenue Next Year
- CLPT $25.50
- CDXS $21.64
- P/E Ratio
- CLPT N/A
- CDXS N/A
- Revenue Growth
- CLPT 19.68
- CDXS N/A
- 52 Week Low
- CLPT $9.76
- CDXS $1.90
- 52 Week High
- CLPT $19.22
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- CLPT 45.80
- CDXS 36.46
- Support Level
- CLPT $10.31
- CDXS $2.37
- Resistance Level
- CLPT $11.45
- CDXS $2.54
- Average True Range (ATR)
- CLPT 0.51
- CDXS 0.13
- MACD
- CLPT 0.03
- CDXS -0.02
- Stochastic Oscillator
- CLPT 30.28
- CDXS 24.14
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.